Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
AcSDKP
Description:
AcSDKP is a thymosin β4-derived tetrapeptide studied for its biological effects, including anti-inflammatory and antifibrotic activity.
Related topics:
Renin-Angiotensin System Studies (15%),
Cardiac Fibrosis and Remodeling (11%),
Hematopoietic Stem Cell Transplantation (11%),
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9%),
Chronic Kidney Disease and Diabetes (8%)
OpenAlex ID:
keywords/acsdkp
Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization
2006
·
Nicola Smart
, Catherine A. Risebro
, et al.
·
Nature
·
674
β-Thymosins, small acidic peptides with multiple functions
2001
·
Thomas Huff
, Christian S.G Müller
, et al.
·
The International Journal of Biochemistry & Cell Biology
·
415
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.
1996
·
M Azizi
, A Rousseau
, et al.
·
Journal of Clinical Investigation
·
361
PDF
The Hemoregulatory Peptide N-Acetyl-Ser-Asp-Lys-Pro Is a Natural and Specific Substrate of the N-terminal Active Site of Human Angiotensin-converting Enzyme
1995
·
Anne Rousseau
, Annie Michaud
, et al.
·
Journal of Biological Chemistry
·
336
PDF
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
2008
·
Yun-He Liu
, Martin D'Ambrosio
, et al.
·
American Journal of Physiology-Heart and Circulatory Physiology
·
306
Signaling by the Angiotensin-Converting Enzyme
2006
·
Ingrid Fleming
·
Circulation Research
·
208
Angiotensin-Converting Enzyme Inhibitors: A New Mechanism of Action
2005
·
Hongmei Peng
, Oscar A. Carretero
, et al.
·
Circulation
·
190
Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides
2012
·
Geoffrey Masuyer
, Sylva L. U. Schwager
, et al.
·
Scientific Reports
·
179
PDF
Levels of Hematopoiesis Inhibitor N -Acetyl-Seryl-Aspartyl-Lysyl-Proline Partially Explain the Occurrence of Anemia in Heart Failure
2005
·
Peter van der Meer
, Erik Lipsic
, et al.
·
Circulation
·
157
Diagnosis and Management of Tuberculous Pericarditis: What Is New?
2020
·
Godsent Isiguzo
, Elsa Du Bruyn
, et al.
·
Current Cardiology Reports
·
155
PDF
Ac-SDKP Reverses Inflammation and Fibrosis in Rats With Heart Failure After Myocardial Infarction
2003
·
Fang Yang
, Xiao-Ping Yang
, et al.
·
Hypertension
·
141
Novel anti-inflammatory mechanisms ofN-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage
2008
·
Umesh Sharma
, Nour-Eddine Rhaleb
, et al.
·
American Journal of Physiology-Heart and Circulatory Physiology
·
139
Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKP
2004
·
Maria A. Cavasin
, Nour-Eddine Rhaleb
, et al.
·
Hypertension
·
134
PDF
Biological activities of thymosin ß 4 defined by active sites in short peptide sequences
2010
·
Gabriel Sosne
, Ping Qiu
, et al.
·
The FASEB Journal
·
131
Involvement of human plasma angiotensin I-converting enzyme in the degradation of the haemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline
1993
·
K J Rieger
, N Saez-Servent
, et al.
·
Biochemical Journal
·
131
PDF
Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP
2014
·
Myeongjin Song
, Hwanseok Jang
, et al.
·
Biomaterials
·
127
Renin-angiotensin system and inflammation update
2021
·
Elena Cantero-Navarro
, Beatriz Fernández-Fernández
, et al.
·
Molecular and Cellular Endocrinology
·
124
Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system
2003
·
Ibrahim C. Haznedaroglu
, M.Akif Öztürk
·
The International Journal of Biochemistry & Cell Biology
·
122
Involvement of thymosin β4 and endoproteinase Asp‐N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system
1990
·
C Grillon
, K Rieger
, et al.
·
FEBS Letters
·
122
PDF
RXP 407, a Selective Inhibitor of the N-Domain of Angiotensin I-Converting Enzyme, Blocks in Vivo the Degradation of Hemoregulatory Peptide Acetyl-Ser-Asp-Lys-Pro with No Effect on Angiotensin I Hydrolysis
2001
·
Christophe Junot
, Marie-Francoise Gonzales
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
118
Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE)
2010
·
Kenneth E Bernstein
, Xiao Z Shen
, et al.
·
Current Opinion in Pharmacology
·
113
High Plasma Level ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline: A New Marker of Chronic Angiotensin-Converting Enzyme Inhibition
1997
·
Michel Azizi
, Eric Ezan
, et al.
·
Hypertension
·
111
Antiinflammatory peptides: current knowledge and promising prospects
2018
·
Maryam Dadar
, Youcef Shahali
, et al.
·
Inflammation Research
·
110
MicroRNA-324-3p Promotes Renal Fibrosis and Is a Target of ACE Inhibition
2012
·
Daniela Macconi
, Susanna Tomasoni
, et al.
·
Journal of the American Society of Nephrology
·
107
Effect ofN-Acetyl-Seryl-Aspartyl-Lysyl-Proline on DNA and Collagen Synthesis in Rat Cardiac Fibroblasts
2001
·
Nour-Eddine Rhaleb
, Hongmei Peng
, et al.
·
Hypertension
·
107
PDF
Show more works
View as search
Works count:
545
Citation count:
13,110
Year
Topic
Type